Factors Associated With Continuation of Exclusive Breastfeeding Until the Post-natal Visit (PoursuitAllait)
December 6, 2022 updated by: Université de Reims Champagne-Ardenne
Breastfeeding promotes the health of mother and her child, and remains the reference in terms of infant nutrition.
World Health Organization recommends exclusive breastfeeding for the first six months.
This recommended duration is not respected in France with a median duration of breastfeeding in France at 3 months.
Study Overview
Detailed Description
The aim is to study factors associated with continuation of exclusive breastfeeding until the post-natal visit.
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: CURRS CURRS
- Phone Number: 0326918822
- Email: currs@univ-reims.fr
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Mother initiating exclusive breastfeeding after birth
Description
Inclusion Criteria:
- primiparous and multiparous women
- women who have initiate breastfeeding
- women aged 18 and more
- agreeing to participate in the study
Exclusion Criteria:
- women whose newborn has been in intensive care unit
- women with a multiple pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
"exclusive breastfeeding" group
Women initiating exclusive breastfeeding after birth
|
continuation of exclusive breastfeeding until the post-natal visit (6 to 8 weeks after birth)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
breastfeeding
Time Frame: Day 0
|
Practicing or not exclusive breastfeeding until postnatal consultation (6 to 8 weeks after birth)
|
Day 0
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
January 1, 2023
Primary Completion (Anticipated)
April 1, 2023
Study Completion (Anticipated)
July 1, 2023
Study Registration Dates
First Submitted
December 6, 2022
First Submitted That Met QC Criteria
December 6, 2022
First Posted (Actual)
December 14, 2022
Study Record Updates
Last Update Posted (Actual)
December 14, 2022
Last Update Submitted That Met QC Criteria
December 6, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 2022_RIPH_013_Poursuit-Allait
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.